Owlet Inc. Reports Record Third‑Quarter 2025 Earnings and Raises Full‑Year Guidance
Owlet Inc. (NASDAQ: OWLT), a health‑technology company headquartered in Lehi, Utah, announced on November 14, 2025 that it delivered record third‑quarter results for the period ended September 30, 2025. The company’s earnings call transcript, released the day before, confirmed the financial highlights and outlined upcoming milestones.
Third‑Quarter 2025 Financial Performance
| Metric | 2025 Q3 | 2024 Q3 | YoY Change |
|---|---|---|---|
| Revenue | $32 million | $22.1 million | +44.6 % |
| Gross Profit | $16.2 million | – | +$? |
| Gross Margin | 50.6 % | 52.6 % | –1.5 pp |
| Adjusted Net Income | $0.5 million | $0.4 million | +$0.1 million |
| Adjusted EBITDA | $1.6 million | $0.6 million | +$1.0 million |
The increase in revenue was primarily driven by sales of the Dream Sock, a wearable infant sock that tracks heart rate, oxygen levels, and sleep trends, and the Dream Duo, an integrated system that pairs the sock with an HD video camera. Gross margin slipped 150 basis points relative to the same period a year earlier, a decline attributed to tariff impacts on input costs.
Full‑Year 2025 Guidance
Following the strong quarter, Owlet lifted its revenue forecast for 2025 to a range of $103 million to $106 million, up from the previously disclosed range of $88 million to $92 million. The company’s 2024 full‑year revenue was $78.1 million, underscoring a clear upward trajectory.
Strategic Milestones
- Commercial Launch in India – Owlet plans to introduce its product line in India in early 2026, targeting a rapidly growing neonatal market.
- Digital Twin Neonatal ICU Market Outlook – A recent industry report projects the digital twin neonatal intensive care unit (ICU) market to reach $1.73 billion by 2029, growing at a CAGR of 24.2 % from 2025 to 2029. Owlet’s focus on proactive monitoring aligns with this expanding market segment.
Market Context
Owlet’s share price closed at $10.16 on November 12, 2025, after a 52‑week high of $11 and a low of $2.75 set in April 2025. The company’s market capitalization stands at approximately $271 million. Its price‑to‑earnings ratio is -3.33, reflecting the company’s ongoing investment in growth.
The company’s financial results and upgraded guidance signal confidence in its product pipeline and international expansion plans, positioning Owlet as a key player in the evolving landscape of smart infant monitoring and neonatal care technology.
